<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01607580</url>
  </required_header>
  <id_info>
    <org_study_id>PUPH IRB [2012] (26)</org_study_id>
    <nct_id>NCT01607580</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD)</brief_title>
  <official_title>Risk Stratification-directed Low-dose Glucocorticoid Prophylaxis for Acute GVHD After Unmanipulated Haploidentical Blood and Marrow Transplantation——a Randomized, Controlled, Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hematopoietic stem cell transplantation (HSCT) is one of the best, and sometimes the only,
      option for the treatment of leukemia. However, GVHD rate was still high after haploidentical
      HSCT.

      It was found in our previous study that CD4/CD8&gt;=1.16、CD56bright NK&gt;1.9×106/kg in the graft
      was associated with higher risk of developing acute Graft-versus-host Disease (GVHD).

      The study hypothesis:

      Risk stratification-directed low-dose glucocorticoid prophylaxis for acute GVHD after
      unmanipulated haploidentical blood and marrow transplantation can reduce the incidence of
      acute GVHD
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      patients undergone haploidentical HSCT following day 5 post transplant were randomized to
      treated group(low-dose glucocorticoid) and controlled group(no intervention).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of acute graft-versus-host disease</measure>
    <time_frame>paticipants will be followed for the duration of hospital stay,an expected average of 100 days</time_frame>
    <description>number of participants with acute graft-versus-host disease at 100 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of infection</measure>
    <time_frame>participants will be followed for the duration of hospital stay,an expected average of 100 days</time_frame>
    <description>number of participants with infection (including bacterium,EB virus, cytomegalovirus and fungus ) at 100 days</description>
  </secondary_outcome>
  <other_outcome>
    <measure>engrafment</measure>
    <time_frame>participants will be followed for the duration of hospital stay,an expected average of 100 days</time_frame>
    <description>numbers of participants with the engrafment of neutrophilic granulocyte and platelets at 100 days</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">145</enrollment>
  <condition>Leukemia</condition>
  <arm_group>
    <arm_group_label>low-dose glucocorticoid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>drug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no intervention after transplant</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>low-dose glucocorticoid Methylprednisolone</intervention_name>
    <description>patients receive low-dose glucocorticoid from day 5 post transplant</description>
    <arm_group_label>low-dose glucocorticoid</arm_group_label>
    <arm_group_label>no intervention after transplant</arm_group_label>
    <other_name>Methylprednisolone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  no severe diarrhea no serious infection

        Exclusion Criteria:

          -  serious diarrhea active,uncontrolled infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University People's Hospital，Institute of Hematology</name>
      <address>
        <city>Beijing</city>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.phbjmu.edu.cn</url>
    <description>hospital website</description>
  </link>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2012</study_first_submitted>
  <study_first_submitted_qc>May 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>January 3, 2014</last_update_submitted>
  <last_update_submitted_qc>January 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Xiaojun Huang</investigator_full_name>
    <investigator_title>director of Peking University People's Hospital，Institute of Hematology</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Glucocorticoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

